Bill Title: As introduced, requires the commissioner of health, in consultation with the commissioner of mental health and substance abuse services, to study and report to the health committee of the house of representatives and the health and welfare committee of the senate, on or before January 15, 2018, concerning any recommended changes to prescribing guidelines for buprenorphine products, or to Tennessee Code Annotated, Section 53-11-311. - Amends TCA Title 53, Chapter 11, Part 3.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2017-02-15 - Assigned to s/c Health Subcommittee
[HB1216 Detail]
Note: Tennessee does not provide sufficient information to determine typical named revision of bills. Therefore only drafts are captured, the highest order draft will always be the current version.
Bill Drafts
| Revision | Date | Format | Source | View |
|---|
| Draft (#1) | 2017-02-09 | PDF | Link | View (#1) |
Amendments
| Amendment | Date | Disposition | Format | Source | View |
|---|
| No bill amendments currently on file for Tennessee HB1216 |
Supplemental Documents
| Title | Description | Date | Format | Source | View |
|---|
| Fiscal Note | HB1216 | Not Avail | PDF | Link | View |
Social Comments on TN HB1216
